Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.48 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.48 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7641652 | 0.86 | MEN1 (0.59) | PTPN1KCNK3KCNK9NPC1RAB9A | |
| SCHEMBL7641330 | 0.86 | NPC1 (0.53) | NPC1RAB9APOLBHDAC1HDAC6 | |
| SCHEMBL11490610 | 0.86 | NPC1 (0.53) | NPC1RAB9AMEN1KMT2AKDM4E | |
| SCHEMBL5607153 | 0.83 | LMNA (0.59) | KCNK3NPC1RAB9AMEN1KMT2A | |
| SCHEMBL10658120 | 0.83 | KMT2A (0.49) | PTPN1MEN1KMT2AMAPTPABPC1 | |
| SCHEMBL7640108 | 0.82 | F10 (0.62) | KCNK9NPC1RAB9AMEN1KMT2A | |
| SCHEMBL10933418 | 0.82 | CACNA1B (0.64) | NPC1RAB9AMEN1KMT2APOLB | |
| SCHEMBL7645837 | 0.82 | NPC1 (0.52) | NPC1RAB9AMEN1KMT2APOLB | |
| SCHEMBL27888664 | 0.82 | MEN1 (0.57) | KCNK3KCNK9NPC1RAB9AMEN1 | |
| SCHEMBL6033544 | 0.82 | SMN1; SMN2 (0.38) | NPC1RAB9AMEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 585 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117165966-A | Method for constructing N-thioether substituted sulfoxide imine derivative through electrochemical promotion | 桂林理工大学 | 2023-12-05 | — | — | CN | claimed |
| US-11834532-B2 | Photoinitiators | IGH RESINS ITALIA S.R.L. (IT) | 2023-12-05 | — | — | US | claimed |
| EP-3902878-A1 | PHOTOINITIATORS | IGM Resins Italia S.r.l. (IT) | 2021-11-03 | — | — | EP | claimed |
| CN-113518805-A | Photoinitiator | 意大利艾坚蒙树脂有限公司 | 2021-10-19 | — | — | CN | claimed |
| WO-2020136522-A1 | PHOTOINITIATORS | IGM RESINS ITALIA S.R.L. (IT) | 2020-07-02 | — | — | WO | claimed |
| US-9090776-B2 | Squarylium dyes | EXCITON, INC. (US) | 2015-07-28 | — | — | US | claimed |
| US-20140061505-A1 | SQUARYLIUM DYES | EXCITON, INC. (US) | 2014-03-06 | — | — | US | claimed |
| EP-2081933-B1 | PYRAZOLOPYRIMIDINES AS PI3K LIPID KINASE INHIBITORS | NOVARTIS AG (CH) | 2011-03-23 | — | — | EP | claimed |
| US-20090306107-A1 | Organic Compounds | NOVARTIS AG (CH) | 2009-12-10 | — | — | US | claimed |
| US-20090286779-A1 | PYRAZOLOPYRIMIDINES AS LIPID KINASE INHIBITORS | NOVARTIS AG | 2009-11-19 | — | — | US | claimed |
| US-4140863-A | 9,11-Dihalo-PG2 compounds | THE UPJOHN COMPANY (US) | 1979-02-20 | — | — | US | claimed |
| US-4136095-A | ANTICOAGULATNS, HYPOTENSIVE AGENTS, ANTIHISTAMINES, DECONGESTANTS | THE UPJOHN COMPANY (US) | 1979-01-23 | — | — | US | claimed |
| US-4131738-A | 6-Hydroxy-PGE1 compounds | THE UPJOHN COMPANY (US) | 1978-12-26 | — | — | US | claimed |
| US-4130720-A | 9-Deoxy-9-methylene-PGF-p-substituted phenyl esters | THE UPJOHN COMPANY (US) | 1978-12-19 | — | — | US | claimed |
| US-4128713-A | 6,7-Didehydro-PGI1 compounds | THE UPJOHN COMPANY (US) | 1978-12-05 | — | — | US | claimed |
| US-4126744-A | PROSTACYCLIN, MUSCLE STIMULANTS, PLATELET AGGREGATION INHIBITORS | THE UPJOHN COMPANY (US) | 1978-11-21 | — | — | US | claimed |
| US-4112224-A | PROSTAGLANDIN | THE UPJOHN COMPANY (US) | 1978-09-05 | — | — | US | claimed |
| US-4110532-A | PROSTAGLANDINS, SMOOTH MUSCLE STIMULANTS | THE UPJOHN COMPANY (US) | 1978-08-29 | — | — | US | claimed |
| US-4109082-A | PROSTACYCLIN ANALOGS; SMOOTH MUSCLE STIMULATORS | THE UPJOHN COMPANY (US) | 1978-08-22 | — | — | US | claimed |
| US-4097489-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1978-06-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286779-A1 | PYRAZOLOPYRIMIDINES AS LIPID KINASE INHIBITORS | ATR, ATM, CHEK1 | PTPN1 449/4885KCNK3 2269/4885KCNK9 2782/4885 |
| US-20090306107-A1 | Organic Compounds | BRAF, MAP3K1, RAF1 | PTPN1 405/4885KCNK3 1776/4885KCNK9 2622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.